About the Forteo Patient Registry
Forteo is used in both men and postmenopausal women with osteoporosis who are at high risk for having broken bones (fractures). Forteo is used in both men and women with osteoporosis due to use of glucocorticoids, such as prednisone, for several months, who are at high risk for having broken bones. Its safety has been studied for over 10 years. The Forteo Patient Registry will help us learn more about the long-term safety of using this medication.
We are asking you to join this registry because your doctor prescribed Forteo. If you live within the 50 United States or Washington, DC and are currently taking Forteo, you are invited to sign up. You don't have to sign up, but registering will help us find out if people taking Forteo are more likely to develop osteosarcoma, a very rare bone cancer. Since 2002, more than 500,000 patients worldwide have received Forteo. It is not known if humans treated with Forteo have a higher chance of getting this bone cancer.
Everyone who takes Forteo is invited to sign up for the registry. If you don't want to sign up, you can still get Forteo at a pharmacy of your choice, just as your doctor has prescribed. If you sign up, you will be asked to provide personal information (such as maiden name or last four digits of your Social Security Number) that will be linked with participating cancer registries in the United States. This will allow us to see if Forteo users have a higher chance of getting this bone cancer than the general population. All information will be kept strictly confidential by RTI International (RTI), the nonprofit research organization conducting the registry on behalf of Eli Lilly and Company (Lilly). Information that can identify you will not be shared with Lilly, the sponsor of this registry, or with anyone outside of the RTI research team.
For more information about the Forteo Patient Registry, see the following resources:
Call the Registry toll-free number at 1-866-382-6813
To sign up for the Forteo Patient Registry, please print, complete, and mail the Pre-Enrollment Form back to us (mailing instructions).
Si desea recibir esta información en español.